New & Noteworthy

February 2022

Ready-to-use Norepinephrine in Premix Formulation

Baxter International, Inc

Baxter launches premix norepinephrine bitartrate in 5% dextrose injection. Norepinephrine is indicated to raise blood pressure in adult patients with severe, acute hypotension. The formulation of norepinephrine is a manufacturer-prepared, ready-to-use formulation and is available in 4 mg/250 mL (16 mcg/mL) and 8 mg/250 mL (32 mcg/mL) strengths. Designed to simplify the preparation process, ready-to-use products can also enhance patient safety by helping minimize potential dosing errors. This product has a shelf life of up to 21 months in a refrigerator, or up to 90 days at room temperature in overwrap. It can also be stored in automated dispensing cabinets at the point of care. Manufactured in accordance with FDA regulations governing current Good Manufacturing Practices (cGMP), this product has received US FDA approval.

Request More Information

Current Issue